Dr. Ankoma-Sey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6560 Fannin St
Scurlock Tower, Suite 1980
Houston, TX 77030Phone+1 713-799-8300Fax+1 713-799-8305
Education & Training
University of California (San Francisco)Fellowship, Gastroenterology, 1993 - 1996
Good Samaritan Hospital of MarylandResidency, Internal Medicine, 1990 - 1993
University of Ghana Medical SchoolClass of 1987
Certifications & Licensure
TX State Medical License 1996 - 2026
CA State Medical License 1993 - 2025
MD State Medical License 1991 - 1994- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Most Compassionate Doctor American Registry
Clinical Trials
- Collection of Plasma and Serum Samples From Individuals Initiating Sofosbuvir for Chronic Hepatitis C for Testing Start of enrollment: 2014 Feb 01
- Collection of Samples for the Clinical Evaluation of the Aptima HBV (Hepatitis B Virus) Quant (Quantification) Assay Start of enrollment: 2014 Mar 01
- Phase I Study of INO-1800 With or Without INO-9112 + EP in Chronic Hepatitis B Subjects Start of enrollment: 2015 Jan 12
- Join now to see all
Publications & Presentations
PubMed
- 136 citationsPeginterferon Alfa-2a and Ribavirin in Latino and Non-Latino Whites with Hepatitis CMaribel Rodriguez-Torres, Lennox J. Jeffers, Muhammad Y. Sheikh, Lorenzo Rossaro, Victor Ankoma-Sey
The New England Journal of Medicine. 2009-12-10 - 90 citationsDevelopment of Quality Measures in Cirrhosis by the Practice Metrics Committee of the American Association for the Study of Liver Diseases.Fasiha Kanwal, Elliot B. Tapper, Chanda Ho, Sumeet K. Asrani, Nadia Ovchinsky
Hepatology. 2019-04-01 - 6 citationsFirst-line therapies for hepatitis B in the United States: A 3-year prospective and multicenter real-world study after approval of tenofovir alefenamide.Calvin Q Pan, Nezam H Afdhal, Victor Ankoma-Sey, Ho Bae, Michael P Curry
Hepatology Communications. 2022-08-01
Grant Support
- Hypoxia And Hepatic FibrogenesisNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2002
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
